Martin Borch Jensen, Ph.D.
Co-Founder and Chief Scientific Officer
Martin Borch Jensen, Ph.D., is co-founder and chief scientific officer of Gordian Biotechnology, the first company to discover novel therapeutic targets for complex diseases through pooled in vivo screening. He led the development of the technology to study disease biology directly inside living organisms and continues to guide therapeutic development across multiple indications. In addition to his work at Gordian, Martin is founder and president of Norn Group, a “do tank” advancing longevity research through grantmaking, talent development, and strategic roadmapping.